Tecovirimat (TPOXX) is the first FDA approved drug treatment of smallpox. In 1980, WHO declared that smallpox was eradicated; however, tecovirimat was developed as a counter to the possible use of smallpox as a bio-weapon. It is the first product awarded a Material Threat Medical Countermeasure priority review voucher by the FDA.
- FDA Approves Spravato (esketamin) Nasal Spray for Treatment-Resistant Depression
- First Treatment for Post-partum Depression FDA Approved
- PEPID’s Founder and CEO Discusses the Challenges and Merits of PGx
- Precision without Fatigue: Focusing on User-experience and Technology to Improve Patient Outcomes
- PEPID to Showcase the First Predictive Pharmacogenetic Drug-Gene Interaction Checker